Since elevated levels of ACE2 and TMPRSS2 indicate a high susceptibility to SARS-CoV-2, and medium-term survivors did not have tumor burden, the expression of ACE2 and TMPRSS2 at resection margin tissue may indicate the susceptibility of lung cancer patients to SARS-CoV-2. This evidence concerns the gene ACE2 and neoplasm.